Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Australia
COVID-19
Western Pacific
Clear all
Type of publications
NITAG documentation
(29)
Topics
Regions
Western Pacific
(29)
Countries
Australia
(29)
China
(26)
Diseases
COVID-19
(29)
Haemophilus influenzae type B
(1)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(1)
Human papillomavirus (HPV)
(9)
Influenza
(10)
Japanese encephalitis
(1)
Meningococcal disease
(6)
Mpox // Monkeypox
(1)
Pertussis
(1)
Pneumococcal disease
(2)
Rotavirus
(1)
Tuberculosis
(1)
Publication date
2023
(5)
2022
(11)
2021
(11)
2020
(2)
Target population
Adults
(1)
Children
(1)
Older adults
(1)
Available to download in languages
English (EN)
(28)
29 results found
2021
∙
ATAGI
ATAGI Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines - 9 August 2021
2021
∙
ATAGI
ATAGI immunisation provider guide to obtaining informed consent for COVID-19 vaccine.
2021
∙
ATAGI
ATAGI statement on SARS-CoV-2 Omicron variant and COVID-19 booster doses
2021
∙
ATAGI
Clinical guidance on use of COVID-19 vaccine in Australia in 2021
2021
∙
ATAGI
COVID-19 vaccination : ATAGI decision guide for people receiving palliative care or end-of-life care - 4 May 2021
2021
∙
ATAGI
COVID-19 vaccination : ATAGI guidance on the use of multi-dose vials for COVID-19 vaccination - 4 May 2021
2021
∙
ATAGI
Joint statement on COVID-19 AstraZeneca vaccine advice from ATAGI - 20 May, 2021
2020
∙
ATAGI
ATAGI COVID-19 Working Group terms of reference and membership
2020
∙
ATAGI
Preliminary advice on general principles to guide the prioritisation of target populations in a COVID-19 vaccination program in Australia
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register